A recent small trial reveals that Bacillus Calmette-Guerin (BCG) therapy significantly improves blood sugar control in adults with long-standing type 1 diabetes by reprogramming white blood cells, independent of pancreatic function. This groundbreaking treatment may transform diabetes management and reduce insulin dependency.